Imagine testing a treatment on a virtual representation of a patient before administering it to the actual patient. This is the concept behind digital twins in healthcare, an emerging technology that combines patient- specific data, computational models and AI to stimulate aspects of an individual’s health and predict potential responses to different interventions.
How could digital twins transform clinical research?
Researchers are exploring their potential in:
-
Clinical trials: Simulating disease progression and supporting trial designs.
-
Personalized medicine: Exploring hoe individual patients might respond to different treatments.
-
Treatment optimization: Evaluating potential therapeutic strategies using patient-specific models.
However, the technology also presents important challenges, including data quality, model validation, confidentiality, and the reliability of predictions in real-world clinical settings. Digital twins could complement traditional clinical trials, but their clinical utility and safety require rigorous validation before adoption.
What is your pov on using digital twins in the clinical trials, and what challenges should the researchers address before relying on these virtual patient models?
MBH/PS